Pages that link to "Q34158366"
Jump to navigation
Jump to search
The following pages link to Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia (Q34158366):
Displaying 50 items.
- Prospective and therapeutic screening value of non-coding RNA as biomarkers in cardiovascular disease (Q26739721) (← links)
- Vascular repair strategies in type 2 diabetes: novel insights (Q26778658) (← links)
- MicroRNAs; easy and potent targets in optimizing therapeutic methods in reparative angiogenesis (Q26785405) (← links)
- MicroRNAs: new insights into chronic childhood diseases (Q26852909) (← links)
- Noncoding RNAs in DNA repair and genome integrity (Q26864697) (← links)
- Roles of microRNAs in atherosclerosis and restenosis (Q27012949) (← links)
- MicroRNA-503 and the extended microRNA-16 family in angiogenesis (Q27026732) (← links)
- MicroRNAs: a new ray of hope for diabetes mellitus (Q27028201) (← links)
- Extracellular microRNAs and endothelial hyperglycaemic memory: a therapeutic opportunity? (Q28079163) (← links)
- The short and long of noncoding sequences in the control of vascular cell phenotypes (Q28080857) (← links)
- Noncoding RNA in age-related cardiovascular diseases (Q28081466) (← links)
- Pathogenesis of diabetic cerebral vascular disease complication (Q28087462) (← links)
- p75(NTR)-dependent activation of NF-κB regulates microRNA-503 transcription and pericyte-endothelial crosstalk in diabetes after limb ischaemia (Q28117855) (← links)
- Dysregulated miR-361-5p/VEGF axis in the plasma and endothelial progenitor cells of patients with coronary artery disease (Q28539143) (← links)
- Human Pericardial Fluid Contains Exosomes Enriched with Cardiovascular-Expressed MicroRNAs and Promotes Therapeutic Angiogenesis. (Q29871466) (← links)
- Aberrant phenotype in human endothelial cells of diabetic origin: implications for saphenous vein graft failure? (Q30642656) (← links)
- Epigenetics: an expanding new piece of the stroke puzzle (Q33352309) (← links)
- Serum microRNA-1 and microRNA-133a levels reflect myocardial steatosis in uncomplicated type 2 diabetes (Q33671476) (← links)
- A PPARγ-dependent miR-424/503-CD40 axis regulates inflammation mediated angiogenesis (Q33746963) (← links)
- Pharmacogenomics of oral antidiabetic medications: current data and pharmacoepigenomic perspective (Q33993320) (← links)
- Cardiomyocytes mediate anti-angiogenesis in type 2 diabetic rats through the exosomal transfer of miR-320 into endothelial cells (Q33995548) (← links)
- miR-503 represses CUG-binding protein 1 translation by recruiting CUGBP1 mRNA to processing bodies (Q34231459) (← links)
- Downregulation of endothelial microRNA-200b supports cutaneous wound angiogenesis by desilencing GATA binding protein 2 and vascular endothelial growth factor receptor 2 (Q34231577) (← links)
- Circulating microRNAs involved in multiple sclerosis (Q34246016) (← links)
- Genetic module and miRNome trait analyses reflect the distinct biological features of endothelial progenitor cells from different anatomic locations (Q34401880) (← links)
- Strategies to deliver microRNAs as potential therapeutics in the treatment of cardiovascular pathology. (Q34485522) (← links)
- Metformin is not just an antihyperglycaemic drug but also has protective effects on the vascular endothelium (Q34505650) (← links)
- Identification of a set of miRNAs differentially expressed in transiently TIA-depleted HeLa cells by genome-wide profiling (Q34578702) (← links)
- The microRNA 424/503 cluster reduces CDC25A expression during cell cycle arrest imposed by transforming growth factor β in mammary epithelial cells (Q34592870) (← links)
- The SUR2B subunit of rat vascular KATP channel is targeted by miR-9a-3p induced by prolonged exposure to methylglyoxal (Q34980484) (← links)
- Integrative analysis of porcine microRNAome during skeletal muscle development (Q34988387) (← links)
- Diabetes complications: the microRNA perspective. (Q35063237) (← links)
- TNF-α and IGF1 modify the microRNA signature in skeletal muscle cell differentiation (Q35077416) (← links)
- MicroRNAs in Human Diseases: From Cancer to Cardiovascular Disease (Q35157020) (← links)
- MicroRNAs in pulmonary arterial hypertension (Q35207669) (← links)
- The genetic basis of peripheral arterial disease: current knowledge, challenges, and future directions (Q35540524) (← links)
- Diabetes and the risk of heart failure (Q35571144) (← links)
- EZH2 modulates angiogenesis in vitro and in a mouse model of limb ischemia (Q35591404) (← links)
- MicroRNAs in Human Diseases: From Autoimmune Diseases to Skin, Psychiatric and Neurodegenerative Diseases (Q35624533) (← links)
- MicroRNA-503 acts as a tumor suppressor in glioblastoma for multiple antitumor effects by targeting IGF-1R (Q35632595) (← links)
- Epigenetic mechanisms of endothelial dysfunction in type 2 diabetes (Q35645997) (← links)
- Hyperglycemia repression of miR-24 coordinately upregulates endothelial cell expression and secretion of von Willebrand factor. (Q35661984) (← links)
- Profiling of circulating microRNAs: from single biomarkers to re-wired networks (Q35792720) (← links)
- MiRNA inhibition in tissue engineering and regenerative medicine (Q35799937) (← links)
- Clinical significance and expression of microRNA in diabetic patients with erectile dysfunction (Q35802924) (← links)
- Endothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer (Q35832970) (← links)
- MicroRNAs as clinical biomarkers? (Q35847902) (← links)
- MicroRNAs in Postischemic Vascular Repair (Q35852407) (← links)
- MicroRNA delivery for regenerative medicine (Q35863950) (← links)
- MicroRNA-134 Contributes to Glucose-Induced Endothelial Cell Dysfunction and This Effect Can Be Reversed by Far-Infrared Irradiation (Q35901547) (← links)